SEARCH

SEARCH BY CITATION

References

  • 1
    Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999; 75: 317.
  • 2
    Mertens TE, Hayes RJ, Smith PG. Epidemiological methods to study the interaction of HIV infection and other sexually transmitted diseases. AIDS 1990; 4: 5765.
  • 3
    Cohen MS. Sexually transmitted diseases enhance HIV transmission: no longer a hypothesis. Lancet 1998; 351 (Suppl. iii): 57.
  • 4
    MacDonald KC, Cameron DW, D’Costa LJ, et al . Evaluation of fleroxacin (RO23-6240) as single oral dose therapy of culture proven chancroid in Nairobi, Kenya. Antimicrob Agents Chemother 1989; 33: 612614.
  • 5
    Plourde PJ, D’Costa LJ, Agoki E, et al . A randomized, double-blind study of the efficacy of fleroxacin versus trimethoprim-sulfamethoxazole in men with culture-proven chancroid. J Infect Dis 1992; 165: 949952.
  • 6
    Bogaerts J, Kestens L, Tello WM, et al . Failure of treatment for chancroid in Rwanda is not related to human immunodeficiency virus infection: in vitro resistance of Haemophilus ducreyi to trimethoprim-sulfamethoxazole. Clin Infect Dis 1995; 20: 924930.
  • 7
    Tyndall M, Malisa M, Plummer FA, et al . Ceftriaxone no longer predictably cures chancroid in Kenya. J Infect Dis 1993; 167: 469471.
  • 8
    Joint United Nations Programme on HIV/AIDS (UNAIDS). Sexually Transmitted Disease: Policies and Principles for Prevention and Care. New York: WHO, 1997: 6.
  • 9
    Risbud A, Chan-Tack K, Gadkari D, et al . The aetiology of genital ulcer disease by multiple polymerase chain reaction and relationship to HIV infection among patients attending sexually transmitted disease clinics in Pune, India. Sex Transm Dis 1999; 26: 5562.
  • 10
    Behets FMT, Braithwaite AR, Hylton-Kong T, et al . Genital ulcers: aetiology, clinical diagnosis, and associated human immunodeficiency virus infection in Kingston, Jamaica. Clin Infect Dis 1999; 28: 10861090.
  • 11
    Chen CY, Ballard RC, Beck-sague CM, et al . Human immunodeficiency virus infection and genital ulcer disease in South Africa: the herpetic infection. Sex Transm Dis 2000; 27: 2129.
  • 12
    Steen R. Eradicating Chancroid.Bull World Health Org 2001; 79: 818826.
  • 13
    Schimid TP, Saunders LL Jr, Blount JH, et al . Chancroid in the United States. Re-establishment of an old disease. J Am Med Assoc 1987; 258: 3265.
  • 14
    Shulte JM, Martrich FM, Schmid GP, et al . Chancroid in the United States. 1981–1990 evidence for underreporting of cases. MMWR 1992; 41 (SS-3): 5761.
  • 15
    Morse SA. Chancroid detected by polymerase chain reaction: Jackson, Mississippi 1994. MMWR 1995; 44: 567574.
  • 16
    Dicarlo RP, Armentar BS, Martin DH, et al . Chancroid epidemiology in New Orleans men. J Infect Dis 1995; 172: 446452.
  • 17
    D’Costa LJ, Plummer FA, Bowmer I, et al . Prostitutes are a major reservoir of sexually transmitted diseases in Nairobi, Kenya. Sex Transm Dis 1985; 12: 64.
  • 18
    Chirgwin K, DeHovitz JA, Dillon S, et al. HIV infection, genital ulcer disease and crack cocaine use among patients attending a clinic for sexually transmitted disease. Am J Public Health1991; 81: 15761579.
  • 19
    Dada AJ, Ajayi AO, Diamond-stone L, et al . A serosurvey of Haemophilus ducreyi, syphilis and herpes simplex virus type 2 and their association with HIV female sex workers in Lagos, Nigeria. Sex Transm Dis 1998: 25: 237242.
  • 20
    Brunham RC, Ronald AR. Epidemiology of sexually transmitted disease in developing countries. In: WasserheifJ, AralS, HolmesKK, eds. Research Issues in Human Behaviour, STD in the AIDS Era. Washington DC: American Society of Microbiology, 1991: 6180.
  • 21
    Hawkes S, West B, Wilson S, et al . Asymptomatic carriage of H. ducreyi, confirmed by the polymerase chain reaction. Genitourin Med 1995; 71: 224227.
  • 22
    Plummer F, D’Costa L, Nsanze H, et al . Epidemiology of chancroid and Haemophilus ducreyi in Nairobi, Kenya. Lancet 1983; 2: 12931295.
  • 23
    Ronald AR, Abritton W. Chancroid and Haemophilus ducreyi. In: HolmesK, SparlingP, MardhP, et al ., eds. Sexually Transmitted Diseases, 3rd edn. New York: McGraw-Hill, 1999: 515523.
  • 24
    Spinola SM, Wild LM, Apicella MA, et al . Experimental human infection with Haemophilus ducreyi. J Infect Dis 1994; 169: 11461150.
  • 25
    Brunham RC, Plummer FA. A general model of sexually transmitted disease epidemiology and its implication for control. Med Clin North Am 1990; 74: 13391352.
  • 26
    Sehgal VN, Srivastava G. Chancroid: contemporary appraisal. Int J Dermatol 2003; 42: 162190.
  • 27
    Abeck D, Korting HC, Zaba R, et al . Soluble interleukin-2 receptors in urine and serum of patients with chancroid and their response to therapy. Int J STD AIDS 1990; 1: 282284.
  • 28
    San Mateo LR, Toffer KL, Kawule TH. The sod A gene of Haemophilus ducreyi encodes a hydrogen peroxide-inhabitable superoxide dismutase. Gene 1998; 207: 251257.
  • 29
    Ward CK, Lumbley SR, Latimer JL, et al . Haemophilus ducreyi secretes a filamentous hemagglutinin-like protein. J Bacteriol 1998; 180: 60136022.
  • 30
    Montero JA, Zaulyanov LL, Houston SH, et al . Sexually transmitted disease. Chancroid: an update. Infect Med 2002; 19: 174178.
  • 31
    Al Tawfiq JA, Thornton AC, Katz BP, et al . Standardization of the experimental model of Haemophilus ducreyi infection in human subjects. J Infect Dis 1998; 178: 168187.
  • 32
    Morse SA, Trees DL, Htun Y, et al . Comparison of clinical diagnosis and standard laboratory and molecular biological methods for the diagnosis of genital ulcer disease in Lesotho: association with human immunodeficiency virus infection. J Infect Dis 1997; 175: 583589.
  • 33
    Olumide YM. A Self-Instructional Textbook of Acquired Immune Deficiency Syndrome. Lagos: Longman, 2002: 45.
  • 34
    Orle KA, Gates CA, Martin DH, et al . Simultaneous PCR detection of Haemophilus ducreyi, Treponema pallidum, and Herpes simplex virus type 1 & 2 from genital ulcers. J Clin Microbiol 1996; 34: 4954.
  • 35
    Totten PN, Kuypers JM, Chen CY, et al . Aetiology of genital ulcer disease in Dakar, Senegal and comparison of PCR serologic assays for detection of Haemophilus ducreyi. J Clin Microbiol 2000; 38: 268273.
  • 36
    Kreiss JK, Coombs R, Plummer F, et al . Isolation of human immunodeficiency virus from genital ulcers in Nairobi prostitutes. J Infect Dis 1989; 160: 380384.
  • 37
    Ghys PD, Fransen K, Diallo MO, et al . The associations between cervicovaginal HIV shedding, sexually transmitted disease and immunosuppression in female sex workers in Abidjan, Cote d’Ivore. AIDS 1997; 11: F85F93.
  • 38
    Fleming DT, Wasserhert JN. From epidemiological synergy to public health policy and practice: the contribution of sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999; 75: 317.
  • 39
    Dyer JR, Eron JJ, Hoffman IF, et al . Association of CD4 cell depletion and elevated blood and seminal plasma human immunodeficiency virus type I (HIV I) RNA concentration with genital ulcer disease in HIV infected men in Malawi. J Infect Dis 1998; 177: 224227.
  • 40
    Van Laer L, Vingerhoets J, Vamham G, et al . In vitro stimulation of peripheral blood mononuclear cells (PBMC) from HIV-negative and HIV-positive chancroid patients by Haemophilus ducreyi antigen. Clin Exp Immunol 1995: 102: 23450.
  • 41
    Cameron DW, Simonsen JN, D’Costa LJ, et al . Female to male transmission of HIV-1: risk factors for seroconversion in men. Lancet 1989; 2: 403407.
  • 42
    Telzak EE, Chiasson MA, Bevier PJ, et al . HIV-1 seroconversion in patients with and without genital ulcer disease. A prospective study. Ann Intern Med 1993; 119: 11811186.
  • 43
    King R, Choudhri SN, Nasio J, et al . Clinical and in-situ cellular responses to H. ducreyi in the presence or absence of HIV infection. Int J STD 1998; 9: 531536.
  • 44
    Plummer FA, Wainberg MA, Ptourde P, et al . Detection of human immunodeficiency virus type 1 (HIV-1) in genital ulcer exudates of HIV infected men by culture and gene amplification. J Infect Dis 1990; 161: 510511.
  • 45
    Sehgal VN, Shyam Prasad AL. Chancroid of chancroidal ulcer. Dermatologica 1985; 170: 136141.
  • 46
    Sehgal VN. Venereal Diseases, 3rd edn. New Delhi: Jaypee Medical Publishers, 1994: 7074.
  • 47
    Jonasson JA. Haemophilus ducreyi. Int J STD AIDS 1993; 4: 317321.
  • 48
    Brown TJ, Yenmoore A, Tyring SK. An overview of sexually transmitted diseases. Part I. J Am Acad Dermatol 1999; 41: 511532.
  • 49
    Ceberry IP, Djeha D, Kacou DE, et al . Chronic genital ulceration and HIV infection: 29 cases. Med Trop (Mars) 1999; 59: 279282.
  • 50
    Rosen T, Brown TJ. Cutaneous manifestation of sexually transmitted disease. Med Clin North Am 1998; 82: 10811104.
  • 51
     WHO. Management of Patients with Sexually Transmitted Disease. WHO Technical Report Series no. 810. Geneva: World Health Organization (WHO), 1991.
  • 52
     Nigeria: Syndromic Management of Sexually Transmitted Infections. A Manual for Health Workers. Abuja: Fed Min of Health, 2001.
  • 53
    Htun Y, Morse SA, Dangor Y et al . Comparison of clinically directed, disease specific, and syndromic protocols for the management of genital ulcer disease in Lesotho. Sex Transm Infect 1998; 74 (Suppl. 1): s23s28.
  • 54
    Schmid GP. Treatment of chancroid. Clin Infect Dis 1999/1997; 28: S14S20.
  • 55
    Tyndall MW, Plourde PJ, Agoki E et al . Fleroxacin in the treatment of chancroid – an open study in men seropositive and seronegative for HIV-1. Am J Med 1993; 94: 855885.
  • 56
    Plummer FA, Maggwan X, D’Costa LJ, et al . Cefotaxime treatment of H. ducreyi infection in Kenya. Sex Transm Dis 1984; 11: 304307.
  • 57
    Rutanarugsa A, Vorachit M, Polnicom N, et al . Drug resistance to Haemophilus ducreyi. South East Asian J Trop Med Public Health 1990; 21: 185193.
  • 58
    Ison CA, Dillon JR, Tapsall JW. The epidemiology of global antibiotic resistance among Neisseria gonorrhoeae and Haemophilus ducreyi. Lancet 1998; 351 (Suppl. 111): 811.
  • 59
    MaeDonald KS, Cameron DW, D’Costa J, et al . Evaluation of fleroxacin (RO 23-6240) as single dose therapy for culture proven chancroid in Nairobi, Kenya. Antimicrob Agents Chemother 1989; 33: 612614.